HFXE ETF Analysis

Diese Seite wurde per KI maschinell aus dem englischen Original übersetzt; die englische Fassung ist maßgeblich. Englische Fassung lesen

Nur zu Informationszwecken. Keine Finanzberatung.

Kurzantwort

In the stored portfolio snapshot dated Mar 15, 2026, the largest listed holding is Nestle SA (NESN) at 4.02%.

HFXE ETF — Price, Holdings & Analysis

ETF-Übersicht

HFXE provides targeted exposure to a select group of European companies, distinguishing itself through its highly. This approach contrasts with more diversified European equity ETFs, which typically hold hundreds of stocks. The fund's strategy centers on investing in established, large-cap companies, as evidenced by its top holdings in Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%). These companies represent a mix of consumer staples and healthcare, indicating a potential focus on stable, dividend-paying stocks. The inclusion of technology companies like ASML Holding NV (1.68%) and SAP SE (1.58%) suggests a blend of traditional and growth-oriented sectors. Investors seeking concentrated exposure to leading European brands may find HFXE appealing, but should be aware of the increased risk associated with a less diversified portfolio. Past performance does not guarantee future results.

Risikokennzahlen

HFXE's introduces a significant level of concentration risk. A downturn in any of its top holdings could have a disproportionately large impact on the fund's overall performance. The fund's sector allocation also contributes to its risk profile, with a notable emphasis on consumer staples and healthcare. While these sectors are generally considered defensive, they may underperform during periods of strong economic growth. With a beta of 0.91, HFXE exhibits slightly lower volatility compared to the broader market. However, the concentrated nature of the fund could amplify its price swings relative to more diversified benchmarks. Investors should carefully consider their risk tolerance and investment horizon before investing in HFXE. Past performance does not guarantee future results.

Beta: 0.91

Was hält HFXE?

Position	Gewichtung
Nestle SA (NESN)	4.02%
Roche Holding AG Dividend Right Cert. (ROG)	3.10%
Novartis AG (NOVN)	2.37%
AstraZeneca PLC (AZN.L)	1.79%
ASML Holding NV (ASML)	1.68%
SAP SE (SAP.DE)	1.58%
Novo Nordisk A/S B (NOVO B)	1.39%
Sanofi SA (SAN.PA)	1.36%
LVMH Moet Hennessy Louis Vuitton SE (MC.PA)	1.34%
GlaxoSmithKline PLC (GSK.L)	1.30%

Bestände und Gewichtungen zum 15. März 2026. Diese Fondsdaten sind älter als 45 Tage; prüfen Sie die aktuellen Bestände beim Emittenten.

Dividendenrendite

2.27%

Fragen & Antworten

What is HFXE and what does it track?

HFXE is an exchange-traded fund (ETF) that provides concentrated exposure to a select group of European equities. Unlike broad-based European equity ETFs, focusing on large-cap, well-established businesses.

The fund's top holdings include names like Nestle SA, Roche Holding AG, and Novartis AG, reflecting a bias towards stable, dividend-paying stocks.

What are the top holdings in HFXE?

HFXE's top holdings reflect its concentrated investment strategy, with a significant portion of its assets allocated to a small number of companies.

As of 2026-03-15, the top three holdings in HFXE are Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%).

Is HFXE a good long-term investment?

Whether HFXE is a suitable long-term investment depends on an individual investor's specific circumstances and risk tolerance. The fund's European equities offers the potential for higher returns, but also carries a greater degree of risk compared to more diversified strategies.

HFXE's dividend yield of 2.27% may appeal to income-seeking investors.

How does HFXE compare to similar ETFs?

HFXE distinguishes itself from similar European equity ETFs through its highly. Most European equity ETFs hold hundreds of stocks, providing broader diversification.

HFXE's concentrated approach may lead to higher returns if its selected companies outperform, but it also increases the risk of underperformance if those companies struggle.

Does HFXE pay dividends?

Yes, HFXE distributes dividends to its shareholders. As of 2026-03-15, HFXE has a dividend yield of 2.27%. This means that for every $100 invested in HFXE, investors can expect to receive approximately $2.27 in dividend income annually.

The dividend yield can fluctuate over time depending on the fund's underlying holdings and market conditions.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Führen Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Daten dienen ausschliesslich zu Informationszwecken.

Maschinell geschrieben, nicht Seite für Seite geprüft. Die redaktionelle Kontrolle ist systemisch: Regeln und Quellen werden geprüft, einzelne Seiten nicht.